Quote:
Originally Posted by Chris
AstraZeneca has published latest data after a surprisingly public rebuke from US authorities. Overall efficacy reduces from 79% to 76% while efficacy in the over 65s improves from 80% to 85%. So hardly worth all the fuss. At either the higher or the lower figures, the Oxford-AstraZeneca vaccine is highly effective.
You have to wonder what the real problem is here. What have Americans and so many Europeans got against a safe, highly effective and easily distributed vaccine being available to the world at cost? 
https://www.bbc.co.uk/news/world-us-canada-56521166 |
I suppose the flip side to that question is what have Astrazenica got against being open and transparent about their data.
Much of this would have been avoided had they not issued the haphazard press release the day after Pfizer claiming 62/70/90% efficacy. Other selective studies have been pulled out at random to come out with other figures.
A 70% efficacy vaccine isn't a bad vaccine. But rather than focus on the positives of availability, cost and relative ease of distribution chains there has been a focus on aiming for a 90% figure.
In other news I got my first dose today.